Markus Gastpar
Impact in
- Psychiatry and Mental health top 0.5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Biological Psychiatry top 1%
Papers in
-
- Schizophrenia research and treatment 47
- Bipolar Disorder and Treatment 25
- Electroconvulsive Therapy Studies 13
-
- Tryptophan and brain disorders 11
- Co-authors
- André TyleeNorbert ScherbaumJulien MendlewiczHans‐Jürgen MöllerAlex GammaJules AngstEugen DavidsSiegfried Kasper
- Journals
- Pharmacopsychiatry (28 papers)Progress in Neuro-Psychopharmacology and Biological Psychiatry (8 papers)European Archives of Psychiatry and Clinical Neuroscience (7 papers)Acta Psychiatrica Scandinavica (6 papers)International Clinical Psychopharmacology (6 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Markus Gastpar
173 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 137
- Psychiatry and Mental health 1.8k
- Biological Psychiatry 281
- Experimental and Cognitive Psychology 664
- Behavioral Neuroscience 168
- Pharmacology 788
Countries citing papers authored by Markus Gastpar
This map shows the geographic impact of Markus Gastpar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Gastpar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Gastpar more than expected).
Fields of papers citing papers by Markus Gastpar
This network shows the impact of papers produced by Markus Gastpar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Gastpar. The network helps show where Markus Gastpar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Gastpar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 19 | |
| 2 | 2012 | 27 | |
| 3 | 2010 | 26 | |
| 4 | 2010 | 123 | |
| 5 | Subsyndromale Angststörungen: Definition, Messparameter, Epidemiologie | 2009 | 7 |
| 6 | 2007 | 38 | |
| 7 | 2005 | 48 | |
| 8 | 2004 | 26 | |
| 9 | 2002 | 0 | |
| 10 | 2002 | 148 | |
| 11 | 2002 | 14 | |
| 12 | [Opinion of the "Ethical and Just Questions" work group for neuropsychopharmacology and pharmacopsychiatry (AGNP)]. | 1999 | 2 |
| 13 | 1998 | 62 | |
| 14 | 1996 | 25 | |
| 15 | 1984 | 1 | |
| 16 | 1980 | 30 | |
| 17 | [Incompatibility of lithium therapy with neuroleptics. a case report (author's transl)]. | 1979 | 2 |
| 18 | [Simultaneous improvement of mood and release of growth hormone by L-5-hydroxytryptophan (Ro 3-5940) in normal subjects (author's transl)]. | 1978 | 0 |
| 19 | 1978 | 19 | |
| 20 | [Intravenous drug administration and hepatitis among young people in Basel]. | 1974 | 1 |
About Markus Gastpar
Markus Gastpar is a scholar working on Psychiatry and Mental health, Biological Psychiatry, Pharmacology, Philosophy and Experimental and Cognitive Psychology, having authored 184 papers that have together received 4.6k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (47 papers), Treatment of Major Depression (32 papers), Bipolar Disorder and Treatment (25 papers), Mental Health and Psychiatry (20 papers), Mental Health Research Topics (14 papers), Electroconvulsive Therapy Studies (13 papers), Opioid Use Disorder Treatment (12 papers) and Tryptophan and brain disorders (11 papers). The work is most often cited by research in Psychiatry and Mental health (1.8k citations), Biological Psychiatry (281 citations), Experimental and Cognitive Psychology (664 citations), Behavioral Neuroscience (168 citations) and Pharmacology (788 citations). Markus Gastpar has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include André Tylee, Norbert Scherbaum, Julien Mendlewicz, Hans‐Jürgen Möller, Alex Gamma, Jules Angst, Eugen Davids, Siegfried Kasper, J. Mendlewicz and Wernér E.G. Müller. Their work appears in journals such as Pharmacopsychiatry, Progress in Neuro-Psychopharmacology and Biological Psychiatry, European Archives of Psychiatry and Clinical Neuroscience, Acta Psychiatrica Scandinavica and International Clinical Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.